RNA
Price:
$31.18
Market Cap:
$3.72B
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.[Read more]
Industry
Biotechnology
IPO Date
2020-06-12
Stock Exchange
NASDAQ
Ticker
RNA
According to Avidity Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.76. This represents a change of 32.57% compared to the average of 13.40 of the last 4 quarters.
The mean historical Current Ratio of Avidity Biosciences, Inc. over the last ten years is 11.04. The current 17.76 Current Ratio has changed 15.99% with respect to the historical average. Over the past ten years (40 quarters), RNA's Current Ratio was at its highest in in the June 2020 quarter at 30.45. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
11.04
Median
10.67
Minimum
0.70
Maximum
22.74
Discovering the peaks and valleys of Avidity Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.23%
Maximum Annual Current Ratio = 22.74
Minimum Annual Increase = -39.03%
Minimum Annual Current Ratio = 0.70
Year | Current Ratio | Change |
---|---|---|
2023 | 7.58 | -36.86% |
2022 | 12.00 | -13.43% |
2021 | 13.86 | -39.03% |
2020 | 22.74 | 143.26% |
2019 | 9.35 | 1.23% |
The current Current Ratio of Avidity Biosciences, Inc. (RNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
11.15
5-year avg
13.11
10-year avg
11.04
Avidity Biosciences, Inc.’s Current Ratio is greater than TCR2 Therapeutics Inc. (2.77), greater than Revolution Medicines, Inc. (14.24), greater than Black Diamond Therapeutics, Inc. (5.55), greater than Atreca, Inc. (1.58), greater than Passage Bio, Inc. (5.15), greater than Akero Therapeutics, Inc. (17.25), greater than Protagonist Therapeutics, Inc. (10.70), greater than Stoke Therapeutics, Inc. (5.09), greater than IGM Biosciences, Inc. (5.22), greater than Cerevel Therapeutics Holdings, Inc. (10.22), less than Cullinan Oncology, Inc. (24.46), greater than Mineralys Therapeutics, Inc. (8.55), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than SpringWorks Therapeutics, Inc. (6.16), less than Relay Therapeutics, Inc. (18.42), greater than Pliant Therapeutics, Inc. (10.26), greater than Arvinas, Inc. (4.17),
Company | Current Ratio | Market cap |
---|---|---|
2.77 | $58.11M | |
14.24 | $8.02B | |
5.55 | $122.22M | |
1.58 | $3.57M | |
5.15 | $40.77M | |
17.25 | $2.00B | |
10.70 | $2.35B | |
5.09 | $604.09M | |
5.22 | $375.22M | |
10.22 | $8.19B | |
24.46 | $701.64M | |
8.55 | $627.09M | |
14.62 | $1.27B | |
6.16 | $2.78B | |
18.42 | $709.70M | |
10.26 | $819.70M | |
4.17 | $1.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avidity Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avidity Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Avidity Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Avidity Biosciences, Inc. (RNA)?
What is the highest Current Ratio for Avidity Biosciences, Inc. (RNA)?
What is the 3-year average Current Ratio for Avidity Biosciences, Inc. (RNA)?
What is the 5-year average Current Ratio for Avidity Biosciences, Inc. (RNA)?
How does the current Current Ratio for Avidity Biosciences, Inc. (RNA) compare to its historical average?